| RIPA | Radio-Immuno(= Immune)-Precipitation(Precipitin) Assay |
|---|---|
| TIG: (human) Tetanus Immune(Immuno-) Globulin | 파상풍 인간 면역 글로불린 |
| AIHD | acquired immune hemolytic disease |
| CIC | cardioinhibitor center; circulating immune complex; clean intermittent catheterization; completely i... |
| CMIR | cell-mediated immune response |
| fish diseases | Diseases of freshwater, marine, hatchery or aquarium fish. This term includes diseases of both teleosts (true fish) and elasmobranchs (sharks, rays and skates). (12 Dec 1998) |
|---|---|
| lacrimal apparatus diseases | Diseases of the lacrimal apparatus. (12 Dec 1998) |
| laryngeal diseases | Disorders of the larynx, general or unspecified. (12 Dec 1998) |
| lipid storage diseases | A series of disorders due to inborn errors in lipid metabolism resulting in the abnormal accumulation of lipids in the wrong places (examples include gaucher, fabry and niemann-pick diseases and metachromatic leukodystrophy). (12 Dec 1998) |
| liver diseases, alcoholic | Liver diseases associated with alcoholism. It usually refers to the coexistence of two or more subentities, i.e., alcoholic fatty liver, alcoholic hepatitis, and alcoholic liver cirrhosis, but may be the general entity when subentities are not specified. (12 Dec 1998) |
| liver diseases, parasitic | Infections of the liver with a parasite. They are caused most commonly by trematodes (flukes). (12 Dec 1998) |
| lung diseases, interstitial | A heterogeneous group of noninfectious, nonmalignant disorders of the lower respiratory tract, affecting primarily the alveolar wall structures but also often involving the small airways and blood vessels of the lung parenchyma. "interstitial" refers to the fact that the interstitium of the alveolar walls is thickened, usually by fibrosis. This group of diseases is usually inflammatory. (12 Dec 1998) |
| lung diseases, obstructive | Any disorder marked by persistent obstruction of bronchial air flow. (12 Dec 1998) |
| lung diseases, parasitic | Infections of the lungs with a parasite. They are caused most commonly by nematodes (roundworms). (12 Dec 1998) |
| lymphatic diseases | Diseases of lymph or lymph vessels. (12 Dec 1998) |
| lysosomal diseases | Diseases (also called storage diseases) in which a deficiency of a particular lysosomal enzyme leads to accumulation of the undigested substrate for that enzyme within cells. Not immediately fatal, but within a few years lead to serious neurological and skeletal disorders and eventually to death. See: the following conditions: Hurler sundrome, Hunter syndrome, San Fillipo, Gaucher's disease, Niemann-Pick, Pompe's disease, Tay Sachs disease. (18 Nov 1997) |
| lysosomal storage diseases | Inborn errors of metabolism characterised by defects in specific lysosomal hydrolases and resulting in intracellular accumulation of unmetabolised substrates. (12 Dec 1998) |
| abdominal muscle deficiency syndrome | <syndrome> Congenital absence (partial or complete) of abdominal muscles, in which the outline of the intestines is visible through the protruding abdominal wall; in males, genitourinary anomalies (urinary tract dilation and cryptorchidism) are also found; genetics unclear. (05 Mar 2000) |
| adult lactase deficiency | Onset of lactase deficiency, with resulting milk intolerance and malabsorption, in adulthood. Inherited forms may not be manifested until adulthood; any process that damages the intestinal lining cells can cause lactase deficiency in adults. (05 Mar 2000) |
| alpha-1 antitrypsin deficiency | <chest medicine> Deficiency of the protease inhibitor alpha-1 antitrypsin, leads primarily to degradation of elastin of the alveolar walls, as well as other structural proteins of a variety of tissues. The lack of this protein leads to damage of various organs, but mainly to the lung and liver. symptoms may become apparent at a very early age or in adulthood, manifesting either as shortness of breath or liver related symptoms (jaundice, fatigue, fluid in the abdomen, mental changes, or gastrointestinal bleeding). There are several options for treatment of the lung disease, including replacement of the missing protein. Treatment of the liver disease is a well-timed liver transplant (12 Dec 1998) |